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Abstract
Background: The aim was to investigate the associations of sarcopenia as defined by European Working Group on Sarcopenia in Older People 
(EWGSOP) and Foundation for the National Institutes of Health (FNIH) Sarcopenia Project, and their underlying components, with the 
incidence of recurrent falling and fractures.
Methods: In 498 older men and women (mean age = 75.2 [SD = 6.4]) from the Longitudinal Aging Study Amsterdam (LASA), the sarcopenia 
components lean mass (DXA), handgrip strength (handheld dynamometer), and gait speed were measured. Data on falls (3-year follow-up) 
and fractures (10-year follow-up) were collected. Cox regression analyses were performed, adjusting for age, sex, and total body fat.
Results: Recurrent falling occurred in 130 persons and 60 persons experienced a fracture during follow-up. Participants who were identified as 
sarcopenic based on the FNIH definitions had a more than 2-fold increased risk to become a recurrent faller. There was no association between 
sarcopenia based on the EWGSOP definition and incidence of recurrent falling. When the sarcopenia components were examined individually, 
only a low grip strength was associated with incidence of recurrent falling, independent of a low lean mass or a slow gait speed. Sarcopenia 
according to both definitions was not associated with incident fractures, which may be caused by low statistical power.
Conclusion: Sarcopenia according to the FNIH definitions, but not according to the EWGSOP definition was associated with recurrent falling. 
When examining the individual components, only a low grip strength was independently associated with recurrent falling. No associations 
between sarcopenia with incidence of fractures were found.
Keywords: Muscle, Gait, Outcomes, Sarcopenia.
The concept of sarcopenia was originally defined as the age-related 
loss of muscle mass by Rosenberg (1). Although the concept is 
widely used in the scientific literature and has been introduced to 
clinical settings, no consensus on the clinical definition of sarcopenia 
has been established yet (2).
Several scientific groups developed operational definitions and 
diagnostic criteria to be used in both scientific research and clin-
ical practice. In 2010, the European Working Group on Sarcopenia 
in Older People (EWGSOP) proposed consensus-based diagnostic 
criteria for age-related sarcopenia using the presence of both low 
muscle mass with either low muscle strength or low gait speed 
(3). In 2014, new criteria for sarcopenia and cut-off scores for 
low muscle mass and low grip strength were developed within 
the Foundation for the National Institutes of Health (FNIH) 
Sarcopenia Project, based on empirical data from a large pooled 
dataset of older persons (4–6).
The prevalence of sarcopenia based on the EWGSOP and FNIH 







edgerontology/article/73/9/1199/4782134 by Vrije U
niversiteit Am
sterdam
 user on 06 N
ovem
ber 2020
1.8% in older women based on data from 10,063 older persons 
(7). These observed sarcopenia prevalence rates were very different, 
and the agreement between the two definitions was very low (7). 
Furthermore, several cut-off scores for low muscle mass (8–12) and 
muscle strength (13,14) have been used in the EWGSOP definition, 
which adds to the variation in published sarcopenia prevalence rates 
based on this definition (15).
To establish a useful definition of sarcopenia, it is important to 
identify which sarcopenia definitions, and which of their underly-
ing components, are associated with important health outcomes. 
However, only few studies have examined the association between 
different definitions of sarcopenia and clinically relevant outcomes 
such as falls (16–18) and fractures (18–20). Therefore, the aim of 
this study is to investigate: (a) the associations between sarcopenia 
as defined by EWGSOP and FNIH definitions and the incidence of 
recurrent falling and fractures, and (b) the association between the 
underlying components of these sarcopenia definitions (low lean 
mass, low muscle strength, and slow gait speed) and the incidence of 
recurrent falling and fractures.
Methods
Study Sample
Data for this study were collected in the context of the Longitudinal 
Aging Study Amsterdam (LASA), an ongoing interdisciplinary 
cohort study on predictors and consequences of changes in auton-
omy and well-being in the aging population in The Netherlands 
(21,22). The sampling and data collection procedures have been 
described in detail elsewhere (23). In brief, a sample of older men 
and women (aged 55–85 years), stratified by age and sex, was drawn 
from the population registries of 11 municipalities in three areas of 
The Netherlands. In total, 3,107 subjects were enrolled in the base-
line examination (1992/1993). Follow-up measurements were done 
every 3 years, consisting of a face-to-face main interview, which was 
carried out at the participant’s home by specially trained interview-
ers. Two to six weeks later, the main interview was followed by a 
medical interview and a separate visit to the hospital or health care 
center. During this visit lean mass was assessed with dual-X ray 
absorptiometry (DXA) (only respondents from Amsterdam and sur-
rounding communities).
For the present study, the baseline study sample included par-
ticipants aged 65 years and older as of January 1, 1996, who par-
ticipated in the main interview and the medical interview of the 
second follow-up of LASA (1995/1996) and who had complete data 
on sarcopenia parameters (lean mass, grip strength, and gait speed, 
n = 498). Of these included respondents, 9 participants had missing 
data on the falls follow-up, resulting in 489 participants included in 
the analyses with incident falling. Fracture follow-up was complete 
for all 498 included respondents.
Muscle Mass
Muscle mass (kilograms) was assessed using DXA (Hologic QDR 
2000 scanner, Hologic, Inc., Waltham, MA) in the enhanced array 
mode and software version V5.70A. We used the sum of fat-free, 
bone-free mass of the arms and legs as lean mass. Low lean mass (kg) 
was determined using sex-specific cut-off scores of <19.75 kg for men 
and <15.02 kg for women, based on the FNIH approach (6). Muscle 
mass index (kg/m2) was calculated by lean mass divided by body 
height squared. Low muscle mass index was determined using sex-
specific cut-off scores of <7.26 kg/m2 for men and <5.45 kg/m2 for 
women, which represents 2 SD below the mean observed in young 
adults (8). These cut-off scores were used in the EWGSOP definition.
Grip Strength
Handgrip strength (kilograms) was measured using a strain-gauged 
dynamometer (Takei TKK 5001, Takei Scientific Instruments Co. Ltd., 
Tokyo, Japan) at the participants’ homes. Participants were asked to 
perform two maximum force trials with each hand. For the final scores, 
the maximum values of the right and the left hand were summed. We 
used sex-specific cut-off scores of <30 kg for men and <20 kg for women 
to define low handgrip strength according to the EWGSOP definition 
(13). We used cut-off scores of <26 kg for men and <16 kg for women 
to define low handgrip strength according to the FNIH definition (5).
Gait Speed
Gait speed was assessed by recording the total time it took to walk 
3 m, make a turn of 180 degrees and walk the 3 m back as quickly 
as possible. We used a cut-off score of ≤0.8 m/s for slow gait speed 
according to the definitions of EWGSOP and FNIH (13).
Sarcopenia Definitions
According to the algorithm developed by the EWGSOP, sarcopenia is 
defined as having both low lean mass and either low muscle strength 
or low gait speed (3). Several definitions were developed by the FNIH, 
including combinations of a low lean mass (absolute or divided by 
body mass index [BMI]), a low grip strength and a slow gait speed (4). 
In the current study, two sarcopenia definitions according FNIH will 
be used. Definition 1: having a low lean mass and a low grip strength. 
Definition 2: having a low lean mass, low muscle strength and a slow 
gait speed.
Recurrent Falling
For a period of 3  years, participants were asked to report their 
falls on a fall calendar every week and to mail the calendar to the 
research center every 3 months. A fall was defined as “an uninten-
tional change in position resulting in coming to rest at a lower level 
or on the ground.” A “recurrent faller” was defined as a subject who 
fell at least two times in 6 months during the 3-year fall follow-up.
Fractures
Fractures were assessed using two different methods. In the first 
3-year period (1995/1996–1998/1999), a fracture calendar was used. 
Participants were instructed to complete a set of questions regarding 
fractures every 3 months, and to send them to our institute. In the sec-
ond 7-year period (1998/1999–2005/2006), fractures were assessed 
during the regular LASA medical interviews. The exact date of the 
fracture was verified with the general practitioner or hospital. Eighty-
three percent of the fractures included in the analyses could be verified.
Confounders
Age and sex were considered confounders in the association between 
sarcopenia parameters and falling and fractures. Furthermore, 
analyses were adjusted for total body fat mass measured by DXA 
(Hologic QDR 2000 scanner, Hologic Inc.), to take the influence of 
body fat into account.
Statistical Analysis
Data were analyzed with SPSS 23.0 (IBM SPSS Statistics). Descriptive 
statistics (mean ± SD, proportions) were calculated for all variables 
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of interest. Cox Proportional-Hazards regression analyses were used 
to assess the time to a second fall of a pair of falls that occurred less 
than 6 months apart, during 3 years of follow-up. These analyses 
were also conducted to assess the time to a fracture during 10 years 
of follow-up. Follow-up time was calculated as the number of days 
from the baseline interview until date of death or the last date of 
contact with the participant until 3 or 10 years of follow-up, respect-
ively. Analyses were done according to the two sarcopenia definitions 
under study. First, the associations of each sarcopenia definition with 
incidence of recurrent falling and fractures were examined. For all 
models, the event rate (proportion of participants who became a 
recurrent faller or experienced a fracture according to sarcopenia 
status) was calculated. Next, the associations of individual sarco-
penia components (low lean mass, low grip strength, and slow gait 
speed) with recurrent falling and fractures were examined using sep-
arate models for each parameter. Cut-off scores of the muscle param-
eters differed, depending on the definition used. Third, to show the 
associations of individual sarcopenia components with incidence 
of recurrent falling and fractures, independent of other sarcopenia 
parameters, a single model was created that included all parameters 
of interest simultaneously. All regression analyses were adjusted for 
age, sex, and total body fat mass.
Results
Table 1 shows the characteristics of the 496 respondents included 
in the statistical analyses. Of the sample, 50.4% was female, and 
the mean age was 75.2 (SD = 6.4) years. Mean lean mass was 18.0 
(SD = 4.2) kg, mean muscle mass index was 6.3 (SD = 1.0) kg/m2, 
mean grip strength was 28.0 (SD = 9.2) kg and mean gait speed was 
0.79 (SD = 0.25) m/s.
The cut-off scores of low lean mass, low muscle strength and 
slow gait speed according to the EWGSOP and FNIH definitions are 
shown in Table 2.
Table  3 shows the prevalence rates of low lean mass (or low 
muscle mass index, in case of the EWGSOP definition), low grip 
strength, and slow gait speed, according to the sarcopenia defini-
tions of the EWGSOP and FNIH. Low muscle mass index was pre-
sent in 52.4% of the study sample, according to the cut-off scores 
of EWGSOP. According to the FNIH definition, low lean mass was 
present in 45.6% of the study sample. A low grip strength was pre-
sent in 28.0% of the study sample according to the EWGSOP and 
in 10.7% according to the FNIH definition. A slow gait speed was 
present in 54.2% of the study sample according to both definitions. 
When we used the complete sarcopenia definitions and algorithms, 
prevalence rates of sarcopenia were 31.9% for the EWGSOP defin-
ition and 7.9% and 6.3% for FNIH definitions 1 and 2.
Table  4 shows the associations between the sarcopenia defini-
tions and incident recurrent falling and fractures. Sarcopenia accord-
ing to the EWGSOP definition was not associated with incidence 
of recurrent falls or with fractures. Both FNIH sarcopenia defini-
tions were associated with an increased risk of becoming a recurrent 
faller (definition 1: hazard ratio (HR) = 2.04 [1.22–3.41]; definition 
2: HR = 2.38 [1.37–4.14]). Event rates were 48.7% vs 24.7% and 
54.8% vs 24.7%, respectively. Both FNIH sarcopenia definitions 
were not associated with incidence of fractures.
Figure 1 shows the HRs of the individual sarcopenia components 
with incidence of recurrent falling according to the cut-off scores 
used for the EWGSOP and FNIH definitions, adjusted for age, sex, 
and total body fat. Low grip strength showed the strongest asso-
ciation with incidence of recurrent falling (HR = 1.60 [1.09–2.37] 
based on the EWGSOP cut-off score and HR 2.05 [1.28–3.28]) 
based on the FNIH cut-off score). Slow gait speed was borderline 
significantly associated with incidence of recurrent falling (HR of 
1.47 [1.00–2.17]). Figure 2 shows the associations between individ-
ual sarcopenia parameters with incidence of fractures. None of the 
parameters was significantly associated with incidence of fractures.
Table  5 shows the associations between individual sarcopenia 
components combined in one model with incidence of recurrent fall-
ing and fractures, respectively. Low grip strength according to the 
EWGSOP suggested cut-off score was significantly associated with 
incidence of recurrent falling (HR 1.51 [1.01–2.25]), independent 
of low muscle mass index and slow gait speed. Similar associations 
were observed for low muscle strength based on the FNIH defin-
ition (HR 2.05 [1.26–3.33]). Low lean mass, muscle mass index and 
slow gait speed were not independently associated with incidence of 
recurrent falling. No independent associations between any sarcope-
nia component and incidence of fractures were observed.
Discussion
We examined the associations of two frequently used sarcopenia def-
initions and their individual components with incidence of recurrent 
Table  1. Characteristics of the Longitudinal Aging Study 
Amsterdam Sample (N = 496)
Age, years 75.2 (6.4)
Sex, % women 50.4
Total body fat, kg 26.8 (9.9)
Muscle mass, kg 18.0 (4.2)
Muscle mass index, kg/m2 6.3 (1.0)
Grip strength, kg 28.0 (9.2)
Gait speed, m/s 0.79 (0.25)
Incidence of recurrent falls, N (%) 130 (26.6)
Incidence of fractures, N (%) 60 (12.1)
Note: Results in mean (SD) unless stated otherwise.
Table 2. Cut-Off Scores of Low Muscle Mass, Low Muscle Strength, and Slow Gait Speed According to the EWGSOP and FNIH Definitions
Muscle Parameter
EWGSOP Definition FNIH Definitions
Men Women Men Women
Low muscle mass ALM/height2 ≤ 7.26 kg/m2 ALM/height2 ≤ 5.45 kg/m2 ALM < 19.75 kg ALM < 15.09 kg
Low grip strength <30 kg <20 kg <26 kg <16 kg
Slow gait speed ≤0.8 m/s ≤0.8 m/s ≤0.8 m/s ≤0.8 m/s
Note: EWGSOP = European Working Group on Sarcopenia in Older People; FNIH = Foundation of the National Institutes of Health sarcopenia project; 
ALM = appendicular lean mass.
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falling and fractures. Participants who were identified as sarcopenic 
based on the FNIH definitions had a more than 2-fold increased 
risk to become a recurrent faller. When the sarcopenia components 
were examined individually, only a low grip strength was associ-
ated with incidence of recurrent falling, independent of a low muscle 
mass or a slow gait speed. Sarcopenia according to both definitions 
was not associated with incident fractures. However, it is important 
to keep in mind that only 60 persons experienced a fracture during 
follow-up, resulting in a low statistical power to detect an associ-
ation. Indeed, post hoc power analyses revealed that a HR of at least 
3.8 (with a power of 0.80 and alpha of 5%) might have given sig-
nificant results for the FNIH definitions in association with fracture 
incidence, assuming that an association actually exists.
Previous studies have examined the association between sarco-
penia and falls. In 2014, a study among older men and women in 
Tasmania (17) revealed that persons in the lowest quintile of grip 
strength had an increased 5-year fall risk, while a low muscle mass 
was associated with fall risk in men only. Our study confirms the 
strongest impact of grip strength on fall risk compared to the other 
sarcopenia components. In a recent study (16) of Bischoff-Ferrari 
et  al., several sarcopenia definitions were compared regarding the 
extent to which they related to 3-year fall rate. The sarcopenia def-
inition according to the definition of the EWGSOP and low muscle 
mass index as defined by Baumgartner et al. (8) predicted rate of falls 
best. In contrast, in our study sarcopenia according to the EWGSOP 
definition was not associated with 3-year fall risk. Findings from the 
Observational Osteoporotic Fractures in Men Cohort Study (MrOS) 
showed that the association between sarcopenia according to both 
the FNIH and EWGSOP definitions and risk of recurrent falling was 
significant. However, further in-depth analyses examining change in 
area under the curve (AUC) for the definitions compared to a refer-
ence model with age alone showed that the discriminative abilities of 
the sarcopenia definitions were poor. Also no improvement in overall 
reclassification was seen when compared to the reference model. It is 
difficult to compare the above mentioned studies with our findings 
due to differences in study sample and differences in the measure-
ment of sarcopenia components, for example, differences in DXA 
machines and differences in grip strength and gait speed assessment.
Recently, in a cohort of 913 older persons aged 63–67  years, 
it was shown that a low muscle mass index was associated with a 
twofold higher 3-year fracture risk, while no significant associations 
were found for other definitions including those from the EWGSOP 
and FNIH (19). In our study, low lean mass according to the FNIH 
cut-off score showed a HR of 1.67 in the association with incidence 
of fractures, but this was not statistically significant. However, the 
models with incident fractures as the outcome might have been 
underpowered to detect a significant association.
Sarcopenia definitions have also been investigated regarding 
their ability to predict other negative health outcomes. The FNIH 
definitions predicted 15-year all-cause mortality in a community-
based sample of 191 older men in Belgium (24). In that study, the 
EWGSOP sarcopenia definition was not examined. Recently, a study 
among older women from the Study of Osteoporotic Fractures 
(SOF) (25) showed that current definitions, including the definitions 
of EWGSOP and FNIH are unable to identify older women with an 
increased risk of greater health care utilization, such as hospitaliza-
tion and short-term stay in a nursing home. Only a slow gait speed 
was associated with a twofold increased risk of greater health care 
utilization. To conclude from previous studies and our current study, 
a sarcopenia definition might be useful to predict one adverse health 
outcome, but not another. Moreover, a sarcopenia definition might 
be useful to predict a certain outcome in one study sample, but not 
in the other.
Although there is general agreement that a sarcopenia definition 
should include a measure of muscle mass as well as measures of 
muscle function, a uniform operational definition is currently not 
Table  3. Prevalence Rates (N (%)) of Low Muscle Mass, Low 
Muscle Strength, and Slow Gait Speed According to the EWGSOP 
and FNIH Definitions
EWGSOP Definition FNIH Definitions
Low muscle mass/ 
muscle mass index
260 (52.4) 226 (45.6)
Low muscle strength 139 (28.0) 53 (10.7)
Slow gait speed 269 (54.2) 269 (54.2)
Figure 1. Adjusted hazard ratios for the association between single sarcopenia 
components and 3-year incidence of recurrent falls among 489 older adults. 
Note: Black squares: hazard ratios of sarcopenia components based on cut-off 
scores of the European Working Group on Sarcopenia in Older People; white 
squares: hazard ratios of sarcopenia components based on cut-off scores of 
the Foundation of the National Institutes of Health sarcopenia project.
Figure 2. Adjusted hazard ratios for the association between single sarcopenia 
components and 10-year incidence of fractures in 496 older adults. Note: Black 
squares: hazard ratios of sarcopenia components based on cut-off scores of 
the European Working Group on Sarcopenia in Older People; white squares: 
hazard ratios of sarcopenia components based on cut-off scores of the 
Foundation of the National Institutes of Health sarcopenia project.
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available. Based on the results of the current study, risk assessment 
of future falls may be conducted by measurement of muscle strength 
only, as this measurement was associated with a twofold increased 
risk of falls, independent of muscle mass and gait speed. However, 
low muscle mass or slow gait speed might be more important risk 
factors for other important clinical health outcomes in older per-
sons. As sarcopenia has received an ICD-10 code recently, which 
is an important step toward better awareness among clinicians, it 
is now warranted to provide clinicians with a useful and feasible 
operational definition of sarcopenia to identify older adults with an 
increased risk of adverse clinical health outcomes. Unfortunately, the 
evidence thus far does not allow a clear advice. Currently, a large fol-
low-up study is being conducted by the FNIH Sarcopenia Working 
Group including more (diverse) cohorts to validate and refine cur-
rent FNIH definitions. This will be another important step toward 
an evidence-based, generally accepted definition of sarcopenia.
Strengths of this study include the use of data of a well-charac-
terized cohort of older men and women and the long follow-up time 
regarding two hard clinical endpoints: incidence of recurrent falling 
and fractures. Several limitations need to be discussed. In the current 
study, we decided to strictly focus on muscle components and there-
fore excluded FNIH definitions that incorporate BMI. Body fat mass 
was however taken into account in the statistical models to expose 
the independent role of muscle components on the risk of recurrent 
falls and fractures. This approach is preferred above using ratios of 
muscle mass divided by BMI as a sarcopenia indicator, as the denom-
inator of this ratio may drive the association between the ratio and 
the outcome. Second, we only included two sarcopenia definitions 
in this study, while more exist (8,9,26–28). We think this selection 
is justified as these two sarcopenia definitions were most recently 
constructed and are most often being used in research and clinical 
practice. Third, the LASA study uses a slightly different gait speed 
measure compared to others; participants are asked to walk 3 m, 
make a turn and walk back 3 m. Therefore, the cut-off score of 0.8 
m/s might be too strict. Indeed, more than 50% of the study sample 
had a slow gait speed according to this cut-off score. Recently, add-
itional data has been collected within the LASA study, including a 3 
m as well as the usual 6 m walk test. Based on these data we were 
able to develop a formula which can be used to recode the time to 
walk 6 m into an estimated time to walk 3 m. When performing sen-
sitivity analyses using this newly created variable, the prevalence rate 
of slow gait speed (≤0.8 m/s) was reduced from 54.2% to 26.5%. 
Similar findings were observed when we included the new variable 
in the models. We observed a HR of 1.31 (0.87–1.98) compared to 
a HR of 1.36 (0.91–2.04) in the association between slow gait speed 
and recurrent falls, independent of low lean mass and low muscle 
strength, based on the EWGSOP definition, and a HR of 1.37 (0.91–
2.05) compared to 1.46 (0.99–2.16) in the association between slow 
gait speed and recurrent falls, independent of low lean mass and low 
muscle strength, based on the FNIH 2 definition.
In conclusion, this study showed an association between the 
FNIH sarcopenia definitions, but not the EWGSOP definition, and 
the risk to become a recurrent faller in older men and women dur-
ing a 3-year follow-up. When examining the individual sarcopenia 
components, a low grip strength was associated with incidence of 
falling, independent of a low lean mass and a slow gait speed. No 
associations between the two sarcopenia definitions, or the individ-
ual sarcopenia components, were observed with incident fractures. 
Table 5. HRs for the Associations Between Individual Sarcopenia Components Combined in One Model With Incidence of Recurrent Falls 
and Fractures
EWGSOP Definition FNIH Definition 1 FNIH Definition 2
Recurrent Falls Fractures Recurrent Falls Fractures Recurrent Falls Fractures
HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
Low muscle mass 0.98 (0.68–1.42) 1.02 (0.60–1.75) 0.97 (0.65–1.43) 1.66 (0.93–2.97) 0.94 (0.63–1.39) 1.67 (0.94–2.99)
Low muscle strength 1.51 (1.01–2.25) 1.05 (0.57–1.93) 2.06 (1.27–3.35) 1.17 (0.55–2.48) 2.05 (1.26–3.33) 1.18 (0.55–2.50)
Slow gait speed 1.36 (0.91–2.04) 0.94 (0.53–1.69) — — 1.46 (0.99–2.16) 0.90 (0.51–1.60)
Note: Models adjusted for age, sex, total body fat, and the other sarcopenia components; see Table 2 for cut-off scores used in the sarcopenia definitions. 
EWGSOP = European Working Group on Sarcopenia in Older People; FNIH = Foundation of the National Institutes of Health sarcopenia project; HR = hazard 
ratio; CI = confidence interval.
Table 4. Adjusted HRs of the Associations Between Sarcopenia Definitions and Incidence of Recurrent Falls and Fractures
Recurrent Falls Fractures
HR (95% CI) ER (%) HR (95% CI) ER (%)
Sarcopenia EWGSOP definition 1.29 (0.89–1.87) 32.7 0.94 (0.54–1.64) 12.0
No sarcopenia 1.0 23.7 1.0 12.1
Sarcopenia FNIH definition 1 2.04 (1.22–3.41) 48.7 1.53 (0.70–3.31) 20.5
No sarcopenia 1.0 24.7 1.0 11.4
Sarcopenia FNIH definition 2 2.38 (1.37–4.14) 54.8 1.41 (0.58–3.43) 19.4
No sarcopenia 1.0 24.7 1.0 11.6
Note: Models adjusted for age, sex, and total body fat. See Table 2 for cut-off scores used in the sarcopenia definitions. EWGSOP = European Working Group on 
Sarcopenia in Older People; FNIH = Foundation of the National Institutes of Health sarcopenia project; HR = hazard ratio; CI = confidence interval; ER = event 
rate.
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Other studies are needed to confirm these findings. Furthermore, 
large studies with a long fracture follow-up are needed to establish 
a possible association between sarcopenia definitions and risk of 
fractures.
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